Type II biotransformations or conjugation reactions are enzyme -catalysed energy-requiring biosyntheses. The ultimate reaction requires a high-energy donor substrate, an acceptor substrate and an appropriate transferase. The high-energy substrate may contain the endogenous conjugating agent (conjugand) (e.g. glucuronic acid, as in UDPGA) or it may contain the xenobiotic (e.g. 4-chlorobenzoic acid, as in 4-chlorobenzoyl-CoA). If the xenobiotic is to be activated to become a donor substrate, other enzymes and high energy substrates (e.g. ATP) are called into action. If we assume for the moment that the low molecular weight substrates for these reactions have equal access to every component in the cell, then the subcellular location of the transferring enzyme will be the controlling factor in the subcellular distribution of the conjugation reaction.
History of the TechniqueThe metabolism of foreign compounds has been studied in various subcellular fractions from about 1950. Brodie and coworkers (1) presented the first overview of the enzyme -catalysed metabolism of these compounds in 1958. In the intervening years, the properties of microsomes and other subcellular fractions in relation to the metabolism and toxicity of drugs, pesticides and, more recently, 'environmental' chemicals have received an enormous amount of study. However, it is interesting to note that the best of the earlier reviews of the enzymology of foreign compound metabolism by J. R. Gillette in 1963 (2) contains the essential details of each of the conjugation reactions referred to below. Progress has not been even: it has proved difficult to keep our treatment of glucuronyltransferase within reasonable limits, yet amino acid conjugation, despite some very interesting species differences, has received very little attention at the enzyme level.For our practical purposes, the animal cell can be regarded as composed of nucleus, endoplasmic reticulum, mitochondria 0-8412-0486-l/79/47-097-181$12.25/0